Roberto Ortiz
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
Papers in
-
- HIV/AIDS drug development and treatment 8
- Antifungal resistance and susceptibility 1
-
- Hepatitis B Virus Studies 2
- Fungal Infections and Studies 1
- Co-authors
- Jan van Lunzen (2 shared papers)Julia Harris (1 shared paper)Clare Brennan (1 shared paper)Bonaventura Clotet (1 shared paper)Irina Magdalena Dumitru (1 shared paper)Tamio Fujiwara (1 shared paper)Andrea Antinori (1 shared paper)Jan Fehr (1 shared paper)
- Journals
- Open Forum Infectious Diseases (4 papers)HIV Clinical Trials (2 papers)AIDS (2 papers)Bone Marrow Transplantation (1 paper)Sexual Health (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Roberto Ortiz
14 papers receiving 1.0k citations
Roberto Ortiz's Hit Papers
Peers
Comparison fields: 5 of 55
- Virology 310
- Infectious Diseases 851
- Emergency Medicine 170
- Epidemiology 188
- Hepatology 32
Countries citing papers authored by Roberto Ortiz
This map shows the geographic impact of Roberto Ortiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Ortiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Ortiz more than expected).
Fields of papers citing papers by Roberto Ortiz
This network shows the impact of papers produced by Roberto Ortiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Ortiz. The network helps show where Roberto Ortiz may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Ortiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study Hit paper breakdown → | 2014 | 361 |
| 2 | 2008 | 285 | |
| 3 | 2014 | 165 | |
| 4 | 2005 | 143 | |
| 5 | 2021 | 34 | |
| 6 | 2008 | 22 | |
| 7 | 2014 | 17 | |
| 8 | 2023 | 11 | |
| 9 | 2018 | 6 | |
| 10 | Gastro-intestinal bleeding in infants and children. | 1953 | 6 |
| 11 | 2021 | 3 | |
| 12 | 2021 | 1 | |
| 13 | 2025 | 1 | |
| 14 | Benign ovarian serous cystadenoma mimicking papillary thyroid carcinoma metastasis on I-131 SPECT/CT. | 2012 | 1 |
| 15 | 2023 | 0 | |
| 16 | 2025 | 0 |
About Roberto Ortiz
Roberto Ortiz is a scholar working on Infectious Diseases, Epidemiology, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Hepatitis B Virus Studies (2 papers), Antifungal resistance and susceptibility (1 paper), HIV-related health complications and treatments (1 paper), Cancer therapeutics and mechanisms (1 paper), Fungal Infections and Studies (1 paper), Vascular Malformations and Hemangiomas (1 paper) and Bone Tumor Diagnosis and Treatments (1 paper). The work is most often cited by research in Virology (310 citations), Infectious Diseases (851 citations), Emergency Medicine (170 citations), Epidemiology (188 citations) and Hepatology (32 citations). Roberto Ortiz has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Jan van Lunzen, Julia Harris, Clare Brennan, Bonaventura Clotet, Irina Magdalena Dumitru, Tamio Fujiwara, Andrea Antinori, Jan Fehr, Vadim Pokrovskiy and Sherene Min. Their work appears in journals such as Open Forum Infectious Diseases, HIV Clinical Trials, AIDS, Bone Marrow Transplantation and Sexual Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.